We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$143M
AUM Growth
+$22.1M
Cap. Flow
+$16.1M
Cap. Flow %
11.27%
Top 10 Hldgs %
29.03%
Holding
133
New
20
Increased
32
Reduced
10
Closed
2

Top Buys

Rank Stock Value
1
NUE icon
Nucor
NUE
+$1.84M
2
PFE icon
Pfizer
PFE
+$1.28M
3
GLOP
GASLOG PARTNERS LP
GLOP
+$1.14M
4
AXP icon
American Express
AXP
+$1.02M
5
GE icon
GE Aerospace
GE
+$786K

Top Sells

Rank Stock Value
1
SRE icon
Sempra
SRE
+$302K
2
TGT icon
Target
TGT
+$232K
3
APC
Anadarko Petroleum
APC
+$130K
4
PANW icon
Palo Alto Networks
PANW
+$67.1K
5
DEO icon
Diageo
DEO
+$56.1K

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Energy 14.28%
3 Industrials 12.78%
4 Technology 10.99%
5 Financials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$656B
$7.32M 5.13%
89,242
+5,050
+6% +$422K
JNJ icon
2
Johnson & Johnson
JNJ
$663B
$5.02M 3.52%
40,304
+4,000
+11% +$478K
BAC icon
3
Bank of America
BAC
$438B
$4.95M 3.47%
209,966
– –
BMY icon
4
Bristol-Myers Squibb
BMY
$136B
$4.92M 3.45%
90,500
+100
+0.1% +$5.49K
IBM icon
5
IBM
IBM
$221B
$4.45M 3.12%
26,749
+2,698
+11% +$452K
PM icon
6
Philip Morris
PM
$284B
$3.78M 2.65%
33,473
+2,400
+8% +$248K
AGN
7
DELISTED
Allergan plc
AGN
$2.77M 1.94%
11,585
– –
PFE icon
8
Pfizer
PFE
$162B
$2.74M 1.92%
84,375
+40,579
+93% +$1.28M
AXP icon
9
American Express
AXP
$220B
$2.73M 1.91%
34,500
+13,100
+61% +$1.02M
MCD icon
10
McDonald's
MCD
$181B
$2.73M 1.91%
21,025
– –
HON icon
11
Honeywell
HON
$66.4B
$2.46M 1.72%
21,765
– –
AAPL icon
12
Apple
AAPL
$4.67T
$2.42M 1.69%
67,248
-200
-0.3% -$6.59K
BPL
13
DELISTED
Buckeye Partners, L.P.
BPL
$2.38M 1.67%
34,740
+9,000
+35% +$613K
DIS icon
14
Walt Disney
DIS
$182B
$2.25M 1.58%
19,890
+850
+4% +$93.6K
MSFT icon
15
Microsoft
MSFT
$3.71T
$2.22M 1.56%
33,706
– –
YUM icon
16
Yum! Brands
YUM
$41.1B
$2.21M 1.55%
34,666
– –
CVS icon
17
CVS Health
CVS
$124B
$2.16M 1.51%
27,498
– –
V icon
18
Visa
V
$700B
$2.02M 1.42%
22,790
– –
ROK icon
19
Rockwell Automation
ROK
$48.2B
$1.89M 1.32%
12,120
– –
BA icon
20
Boeing
BA
$168B
$1.88M 1.32%
10,630
– –
T icon
21
AT&T
T
$176B
$1.83M 1.28%
58,354
+6,052
+12% +$190K
DD icon
22
DuPont de Nemours
DD
$17.8B
$1.81M 1.27%
11,242
+2,053
+22% +$319K
NUE icon
23
Nucor
NUE
$59.2B
$1.79M 1.26%
+30,050
New +$1.84M
XIFR
24
XPLR Infrastructure LP
XIFR
$1.14B
$1.79M 1.25%
54,000
– –
GE icon
25
GE Aerospace
GE
$350B
$1.78M 1.25%
12,440
+5,427
+77% +$786K
1
2 3 4 5

Similar funds

THL
Tillman Hartley LLC Denver, Colorado $445M AUM 19.58% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $445M AUM 35.1% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return
LWPC
Legacy Wealth Partners (Colorado) Lakewood, Colorado $445M AUM
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $445M AUM 42.75% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $446M AUM 21.49% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
CFS
CGC Financial Services Lake Oswego, Oregon $445M AUM 17.73% 1-Year Est. Return

Searle & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Searle & Co held 133 positions worth $143M, up 18% from $121M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Searle & Co deployed $16.1M of net new capital in Q1 2017, opening 20 new positions and adding to 32 existing holdings. Its largest new stake was Nucor: 30,050 shares worth $1.79M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Anadarko Petroleum, an estimated $130K trimmed.

  • Searle & Co's largest Q1 2017 buy was Nucor: 30,050 shares worth $1.79M.
  • Searle & Co added most to Pfizer in Q1 2017, an estimated $1.28M increase.
  • Searle & Co's biggest Q1 2017 reduction was Anadarko Petroleum, cutting an estimated $130K.
  • Searle & Co fully exited Sempra in Q1 2017, selling an estimated $302K.
  • Searle & Co's ten largest holdings make up 29% of its $143M portfolio in Q1 2017.
  • Searle & Co opened 20 new positions and closed 2 in Q1 2017.
  • Searle & Co's portfolio value rose 18% quarter-over-quarter to $143M.

Based on Searle & Co's 13F filing for Q1 2017, filed 2 May 2017.